Dallah Healthcare Co. · TADAWUL:4004
Dallah Healthcare — Q1 2024 Earnings Presentation
23 slides from Dallah Healthcare's earnings presentation, 2024
Slide 1: Dallah Healthcare Co. Q1 2024
Dallah Healthcare Co. Q1 - 2024
Slide 2: DHC's mission and vision, guided by core values
DHC’s mission and vision … … guided by core values Mission Values To deliver excellent healthcare services Care and respect for our patients, which are consistent with our values and their needs and our society with the expectation of our patients, society, and partners Commitment to professional et
Slide 3: Dallah Healthcare Company offers an attractive investment opportunity
DHC has long been established in KSA and has shown year-on-year growth DHC has a strong product portfolio, consistently growing to address the evolving needs of patients Dallah Healthcare Company offers an DHC has numerous certifications positioning it at the forefront in terms of service excellence
Slide 4: History: DHC has a long legacy in KSA healthcare
Dallah Hospital- 1987 Al Nakheel Dallah Pharma 2002 Dallah Ob-gyne 2007 DHC listing 2012 Dallah Pediatrics 2013 Jordanian Pharmaceuticals Co. Afyaa Al Nakheel 2014 and DMRF North clinics 2015 quite rapidly both organically and inorganically Dallah Hospital- 2018 Namar Dallah Al Nakheel Meras Arabia
Slide 5: DHC owns and directly operates five categories of companies
Dallah Health Company Portfolio Today, DHC owns and directly operates five categories of companies while also engaging in active management of portfolio investments Owned & operated by DHC Portfolio investments (ownership share, %) Makkah Medical Medical check-up center, targeting Center (92%) low t
Slide 6: With +1811 beds currently, DHC aims to further expand
Dallah Health Company Portfolio With +1811 beds* currently, DHC aims to further Future projects expand to meet future demand Combined current capacity at +1811 beds across DHC's operational entities 1 Dallah Al Aarid Hospital: and investments • Land: 45,000 sqm • Built-up area: 87,300 sqm • 250 Beds
Slide 7: Future projects
Dallah Health Company Portfolio Future projects 6
Slide 8: DHC's presence over the Kingdom of Saudi Arabia
Dallah Health Company Portfolio DHC's presence over the Kingdom of Saudi Arabia 7
Slide 9: The array of medical services offered by DHC hospitals
Dallah Health Company Portfolio The array of medical services offered by DHC hospitals extends across various specialties, complemented by supplementary support services 25+ Medical and Nursing Services 4+ key Ancillary Services Medical services under the following therapy areas: Supplementary suppo
Slide 10: DHC's hospitals have demonstrated consistent patient volume growth
Dallah Health Company Portfolio Over the past 5 years, DHC's hospitals have demonstrated consistent patient volume growth, a trend evident when comparing Q1-23 with Q1-24 Patient volume (in 000s) CAGR 19% 2,679 1% 2,252 1,800 1,166 968 674 682 2019 2020 2021 2022 2023 Q1-23 Q1-24 * MMC and KHCC was
Slide 11: Dallah Pharma serves as another strong operational asset within DHC
Dallah Health Company Portfolio Dallah Pharma serves as another strong operational asset within DHC, with a presence across various locations in KSA and supported by renowned partners … with a strong product portfolio … supported by renowned and well- spanning across 6 categories … established partn
Slide 12: DHC has acquired several certifications, accreditations and awards
Dallah Health Company Accreditations When addressing service excellence and patient safety, DHC has acquired several well-regarded certifications, accreditations, and awards One of the first hospitals in Dallah Hospital laboratory Dallah Hospitals catering Saudi Arabia awarded JCI certified by the C
Slide 13: DHC's future growth is supported by its well-defined 5-year strategy
Dallah Health Company Growth Strategy & Leadership DHC's future growth is supported by its well-defined 5-year strategy anchored around a coherent direction for the diversified portfolio Deep-dive included in the next slides Operating companies Investments Become a one-stop shop for VIP/A privately
Slide 14: To become a 'one-stop high-end' service provider
Dallah Health Company Growth Strategy & Leadership To become a 'one-stop high-end' service provider, DHC will selectively specialize as well as expand into clinics, telemedicine, post-acute care and homecare Value One-stop-shop high-end provider First point of contact from the cradle to the grave Pr
Slide 15: DHC has experienced growth between Q1-23 and Q1-24
Dallah Health Company Financial Performance Regarding its financial performance, DHC has experienced growth between Q1-23 and Q1-24 Key consolidated financial results (M SAR) Q1-23 Q1-24 Revenues 717 9% 784 EBITDA 167 17% 195 EBIT 136 18% 160 Net Profit 101 26% 127 Net Profit attributable to common
Slide 16: Financial results over 5 years (1/5): Revenues
Dallah Health Company Financial Performance The trend of financial growth extends prior to 2022 and is supported by DHC's financial results over 5 years (1/5) Revenues (M SAR) 2,943 CAGR 9% 20% 2,488 2,105 1,318 1,252 784 717 2019 2020 2021 2022 2023 Q1-23 Q1-24 15
Slide 17: Financial results over 5 years (2/5): Gross Profit
Dallah Health Company Financial Performance The trend of financial growth extends prior to 2022 and is supported by DHC's financial results over 5 years (2/5) 1400 1200 Gross Profit (M SAR) 40% 40% 37% 37% 37% CAGR 36% 36% 36% 1200 11% 23% 34% 1000 35% 35% 1079 1000 30% 30% 800 895 800 25% 25% 760 6
Slide 18: Financial results over 5 years (3/5): EBIT
Dallah Health Company Financial Performance The trend of financial growth extends prior to 2022 and is supported by DHC's financial results over 5 years (3/5) 1000 30% 800 30% EBIT (M SAR) 900 CAGR 700 17% 26% 25% 25% 800 600 700 20% 20% 19% 20% 500 600 17% 17% 17% 500 14% 15% 400 15% 504 400 11% 42
Slide 19: Financial results over 5 years (4/5): EBITDA
Dallah Health Company Financial Performance The trend of financial growth extends prior to 2022 and is supported by DHC's financial results over 5 years (4/5) 1000 30% 800 30% EBITDA (M SAR) 900 CAGR 700 25% 17% 22% 25% 25% 800 23% 22% 21% 21% 21% 600 700 20% 20% 18% 500 600 630 500 15% 400 15% 514
Slide 20: Financial results over 5 years (5/5): Net Profit
Dallah Health Company Financial Performance The trend of financial growth extends prior to 2022 and is supported by DHC's financial results over 5 years (5/5) 1200 Net Profit (M SAR) 1200 40% 40% CAGR 26% 16% 1000 35% 35% 1000 30% 30% 800 800 25% 25% 600 600 20% 20% 16% 15% 14% 15% 13% 13% 400 400 1
Slide 21: Debt-to-EBITDA ratio decreasing year on year
Dallah Health Company Financial Performance As for its debt-to-EBITDA ratio, DHC is pursuing YoY decreases through more informed capital allocation strategies during its expansion Debt-to-EBITDA (M SAR) 3.8x 6.5x 4.2x 3.7x 3x 3x 2.5x 1,935 1,895 1,899 1,867 1,840 1,515 1,021 630 514 449 269 234 167
Slide 22: DHC achieved its highest return on equity in the past 3 years
Dallah Health Company Financial Performance DHC achieved its highest return on equity in the past 3 years averaging between 12% to 14% Return on Equity (M SAR) 14% 14% 13% 11% 12% 9% 7% 2019 2020 2021 2022 2023 Q1-23 Q1-24 21
Slide 23: Thank you
Thank you